Health Care: Drugs

Peregrine Pharmaceuticals Inc (PPHM: NASDAQ)

$4.6 n/a | n/a%
07/21/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 4.60
52 Week High 5.78
52 Week Low 1.97
Avg. Daily Vol. (Mil) 0.23
Beta (3 year) 3.04
Share Related Items
Mkt Cap (Mil) 207.32
Shares Out (Mil) 45.07
Float (Mil) 30.56
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.90
Current Ratio 1.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 3.60
Price/Book 3.87
Price/Cash Flow -6.80
Per Share Data
Earnings -0.88
Sales 1.28
Book Value 1.19
Cash Flow -0.67
Business Summary
Peregrine Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It develops novel investigational products that help utilize the immune system to fight cancer, also known as immunotherapy.
General Information
14282 Franklin Avenue
Tustin, CA 92780
Industry : Drugs
Sector: Health Care
Employees: 319
CEO: Mr. Steven W. King
Short Interest
Current Month (Mil) 1.46
Previous Month (Mil) 1.46
Short Interest Ratio (Days) 1.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -23.80
Return on Investments -52.60
Gross Margin 37.90
EBIT Margin -48.80
Profit Margin -48.90

Portfolios with PPHM

Latest PPHM Headlines from TheStreet

More Financial News for PPHM

Press Releases for PPHM

See All Press Releases

Partner Headlines for PPHM

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter